When inflammation eats muscle, fast-twitch fibres go first
In short
A review mapping the muscle-wasting pathways that accompany cancer immunotherapy found that very different signals funnel into one common junction. Fibroblast-derived TGF-β, glycolysis-derived lactate, and IL-6/TNF-α inflammatory cascades all switch on the myostatin/FoxO3 transcriptional program and ubiquitin-proteasome proteolysis. The tissue most exposed to that damage is type II fast-twitch glycolytic fibres and muscle satellite cells. Corticosteroid exposure, age and sex hormones stratified how badly any given patient was affected.
Muscle loss usually gets discussed as one undifferentiated thing. This review opens it up and asks which signal takes down which fibre first. Its subject is the skeletal muscle dysfunction that follows five families of combination immunotherapy — chemoimmunotherapy, targeted immunotherapy, gene therapy, tumour vaccines and CAR-T. The treatments have little in common; what happens inside the muscle converges to a striking degree.
Why do unrelated triggers produce the same outcome?
Because there is one junction. TGF-β released by cancer-associated fibroblasts, lactate accumulating from glycolysis, and the inflammatory cascades led by IL-6 and TNF-α all activate the myostatin/FoxO3 transcriptional program, and downstream of it the ubiquitin-proteasome system breaks muscle protein down. The balance between synthesis and breakdown is held on the breakdown side — a different starting point from the atrophy of simply not training.
Why fast-twitch fibres first?
The review singles out type II glycolytic fast-twitch fibres and muscle satellite cells as disproportionately susceptible to inflammatory and metabolic damage. Fast-twitch fibres carry maximal force and speed; satellite cells do the repairing. Hit both at once and the result is predictable: bodyweight and limb circumference barely move while maximal strength and power drop first, and recovery between sessions slows alongside.
Why does severity differ between people?
The review names corticosteroid exposure, chronological age and sex hormones as the clinical factors that stratify vulnerability. Corticosteroids in particular push protein breakdown on their own, so using them during an inflammatory state drives the same pathway from two directions. On the measurement side, electrical impedance myography is highlighted as sensitive enough to pick up tissue remodelling before it becomes clinically obvious.
What should a lifter watch?
Move the metric from size to output. Through any prolonged inflammatory stretch — treatment, a long infection, a chronic inflammatory condition — the scale and the tape measure are late indicators. What moves first are the numbers fast-twitch fibres own: maximal strength, bar speed, jump height. This is where the fact that size and strength do not always move together becomes practical rather than academic.
Read those numbers the same way as any other: not one value but the slope across several months. Converting big-three lifts through the same formula each time keeps dates comparable even when bodyweight is drifting. And note what topped the review's list of muscle-protective measures: not a drug, but structured resistance training. Scale the load and the volume to the situation, but removing the stimulus entirely is the worst available option.
This review covers patients on cancer immunotherapy. The myostatin/FoxO3 pathway itself is shared with other inflammatory states, but the magnitude of vulnerability described here does not transfer to a healthy person with a cold or a passing inflammatory episode. Exercise during treatment is a decision to make with your clinical team.
Frequently asked questions
How does inflammation break muscle down?
TGF-β, lactate and the IL-6/TNF-α inflammatory cascades all activate the myostatin/FoxO3 transcriptional program, and the ubiquitin-proteasome system degrades muscle protein downstream of it. The triggers are varied; the junction they meet at is single.
Why are fast-twitch fibres damaged first?
The review reports that type II glycolytic fast-twitch fibres and muscle satellite cells are disproportionately susceptible to inflammatory and metabolic damage. Fast-twitch fibres produce maximal force and power while satellite cells handle repair, so hitting both drops output before it changes physique.
Is losing strength at a stable bodyweight still muscle loss?
It can be. When type II fibres are damaged first, maximal strength, bar speed and jump height fall while weight and circumference hold steady. Tracking size alone misses it.
How do steroids affect this?
Corticosteroid exposure is one of three clinical factors the review names as stratifying vulnerability, alongside age and sex hormones. Corticosteroids drive muscle protein breakdown themselves, so combining them with an inflammatory state activates the same pathway from both sides.
Should you resistance train during an inflammatory period?
Structured resistance training headed the review's list of muscle-protective interventions, ahead of nutritional support and anti-cachexia pharmacotherapy. Since the population studied was patients under treatment, intensity and volume should be set with a clinical team.
Source: PubMed